Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-05

FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s supplemental application for solifenacin succinate (ANDA205483), confirming continued approval of the generic product. Sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (solifenacin)

Snippet

SUPPL AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)